Dolby Laboratories, Inc.
DLB
$67.48
$1.973.01%
NYSE
| 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.33M | 46.07M | 91.79M | 67.82M | 58.57M |
| Total Depreciation and Amortization | 24.58M | 24.40M | 24.43M | 25.20M | 24.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.10M | 22.70M | 25.12M | 26.68M | 33.63M |
| Change in Net Operating Assets | -12.17M | -25.48M | 33.56M | -12.92M | -411.00K |
| Cash from Operations | 122.83M | 67.69M | 174.90M | 106.78M | 116.17M |
| Capital Expenditure | -16.24M | -6.43M | -6.90M | -6.78M | -7.38M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 16.88M | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -1.36M | -487.88M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.67M | 0.00 | 15.91M | -- | 233.95M |
| Cash from Investing | -21.91M | -6.43M | 25.90M | -8.14M | -261.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.02M | 12.56M | 3.97M | 22.16M | 716.00K |
| Repurchase of Common Stock | -37.08M | -41.20M | -36.77M | -47.44M | -21.65M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -31.59M | -31.63M | -31.83M | -31.55M | -28.61M |
| Other Financing Activities | -398.00K | -468.00K | -241.00K | -740.00K | -10.58M |
| Cash from Financing | -64.06M | -60.74M | -64.87M | -57.57M | -60.12M |
| Foreign Exchange rate Adjustments | -67.00K | 5.70M | 2.77M | -7.16M | 4.38M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.80M | 6.22M | 138.69M | 33.91M | -200.87M |